[
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: David Fenyo + Drew Jones",
    "opportunity_id": "d8de0550-c5b0-4efc-872a-7777a933452b",
    "opportunity_number": "DFOP0017042",
    "opportunity_title": "Notice of Intent:  Program to End Modern Slavery FY 2025",
    "members": [
      "David Fenyo",
      "Drew Jones"
    ],
    "member_ids": [
      "intake_david_fenyo",
      "intake_drew_jones"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 29.0,
    "opportunity_url": "https://mygrants.servicenowservices.com/mygrants?id=mygrants_form&table=x_g_usd4_d_grant_funding_opportunity&sys_id=866456e4479aded067358810326d438a&view=Default",
    "suggested_title": "DFOP0017042 — Biochemistry: work, which, research, have",
    "synopsis": "This application would address Notice of Intent:  Program to End Modern Slavery FY 2025 by integrating complementary expertise across the team. The proposed collaboration is centered on work, which, research, have and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Drew Jones: The ongoing theme of my work is the invention or adaptation of advanced chromatography and mass spectrometry technology to tackle challenging analytical problems with a translational potential. Methodologically, much of my science is designed around using high throughput LC-MS as the analytical readout of biochemical experiments.; David Fenyo: In my research I apply mathematical, statistical and computational methods to provide a detailed understanding of the dynamics of cellular processes through the integration and visualization of data from multiple technologies—including mass spectrometry, next generation sequencing, and microscopy to provide a deeper understanding of biological systems. My focus is the analysis of analytical measurements: the estimation of the information content of these measurements from different experimental designs, and the optimal use of such information to yield statistically meaningful answers to biological questions..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in work, which, research, have using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Nadav Brandes + Paolo Mita",
    "opportunity_id": "d8de0550-c5b0-4efc-872a-7777a933452b",
    "opportunity_number": "DFOP0017042",
    "opportunity_title": "Notice of Intent:  Program to End Modern Slavery FY 2025",
    "members": [
      "Nadav Brandes",
      "Paolo Mita"
    ],
    "member_ids": [
      "intake_nadav_brandes",
      "intake_paolo_mita"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 29.0,
    "opportunity_url": "https://mygrants.servicenowservices.com/mygrants?id=mygrants_form&table=x_g_usd4_d_grant_funding_opportunity&sys_id=866456e4479aded067358810326d438a&view=Default",
    "suggested_title": "DFOP0017042 — Biochemistry: human, which, potential, research",
    "synopsis": "This application would address Notice of Intent:  Program to End Modern Slavery FY 2025 by integrating complementary expertise across the team. The proposed collaboration is centered on human, which, potential, research and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in human, which, potential, research using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: David Fenyo + Drew Jones",
    "opportunity_id": "e66f1f91-42dc-4a57-acba-8986d3e08df1",
    "opportunity_number": "DE-FOA-0002265",
    "opportunity_title": "University Nuclear Leadership Program– Scholarship and Fellowship Support",
    "members": [
      "David Fenyo",
      "Drew Jones"
    ],
    "member_ids": [
      "intake_david_fenyo",
      "intake_drew_jones"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 38.0,
    "opportunity_url": "https://neup.inl.gov/SitePages/Home.aspx",
    "suggested_title": "DE-FOA-0002265 — Biochemistry: work, which, research, improving",
    "synopsis": "This application would address University Nuclear Leadership Program– Scholarship and Fellowship Support by integrating complementary expertise across the team. The proposed collaboration is centered on work, which, research, improving and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Drew Jones: The ongoing theme of my work is the invention or adaptation of advanced chromatography and mass spectrometry technology to tackle challenging analytical problems with a translational potential. Methodologically, much of my science is designed around using high throughput LC-MS as the analytical readout of biochemical experiments.; David Fenyo: In my research I apply mathematical, statistical and computational methods to provide a detailed understanding of the dynamics of cellular processes through the integration and visualization of data from multiple technologies—including mass spectrometry, next generation sequencing, and microscopy to provide a deeper understanding of biological systems. My focus is the analysis of analytical measurements: the estimation of the information content of these measurements from different experimental designs, and the optimal use of such information to yield statistically meaningful answers to biological questions..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in work, which, research, improving using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Nadav Brandes + Paolo Mita",
    "opportunity_id": "e66f1f91-42dc-4a57-acba-8986d3e08df1",
    "opportunity_number": "DE-FOA-0002265",
    "opportunity_title": "University Nuclear Leadership Program– Scholarship and Fellowship Support",
    "members": [
      "Nadav Brandes",
      "Paolo Mita"
    ],
    "member_ids": [
      "intake_nadav_brandes",
      "intake_paolo_mita"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 33.0,
    "opportunity_url": "https://neup.inl.gov/SitePages/Home.aspx",
    "suggested_title": "DE-FOA-0002265 — Biochemistry: knowledge, research, which, potential",
    "synopsis": "This application would address University Nuclear Leadership Program– Scholarship and Fellowship Support by integrating complementary expertise across the team. The proposed collaboration is centered on knowledge, research, which, potential and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in knowledge, research, which, potential using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Michele Pagano + Nadav Brandes",
    "opportunity_id": "cd4dd647-b2b4-49d9-aac3-0033d0eb434c",
    "opportunity_number": "DE-FOA-0003164",
    "opportunity_title": "SPURRING PROJECTS TO ADVANCE ENERGY RESEARCH AND KNOWLEDGE SWIFTLY (SPARKS)",
    "members": [
      "Michele Pagano",
      "Nadav Brandes"
    ],
    "member_ids": [
      "intake_michele_pagano",
      "intake_nadav_brandes"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 64.0,
    "opportunity_url": "https://arpa-e-foa.energy.gov",
    "suggested_title": "DE-FOA-0003164 — Biochemistry: more, can, which, have",
    "synopsis": "This application would address SPURRING PROJECTS TO ADVANCE ENERGY RESEARCH AND KNOWLEDGE SWIFTLY (SPARKS) by integrating complementary expertise across the team. The proposed collaboration is centered on more, can, which, have and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in more, can, which, have using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: David Fenyo + Gregory David",
    "opportunity_id": "cd4dd647-b2b4-49d9-aac3-0033d0eb434c",
    "opportunity_number": "DE-FOA-0003164",
    "opportunity_title": "SPURRING PROJECTS TO ADVANCE ENERGY RESEARCH AND KNOWLEDGE SWIFTLY (SPARKS)",
    "members": [
      "David Fenyo",
      "Gregory David"
    ],
    "member_ids": [
      "intake_david_fenyo",
      "intake_gregory_david"
    ],
    "rationale": "Shared terms: research",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 45.0,
    "opportunity_url": "https://arpa-e-foa.energy.gov",
    "suggested_title": "DE-FOA-0003164 — Biochemistry: including, have, research, focus",
    "synopsis": "This application would address SPURRING PROJECTS TO ADVANCE ENERGY RESEARCH AND KNOWLEDGE SWIFTLY (SPARKS) by integrating complementary expertise across the team. The proposed collaboration is centered on including, have, research, focus and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: David Fenyo: In my research I apply mathematical, statistical and computational methods to provide a detailed understanding of the dynamics of cellular processes through the integration and visualization of data from multiple technologies—including mass spectrometry, next generation sequencing, and microscopy to provide a deeper understanding of biological systems. My focus is the analysis of analytical measurements: the estimation of the information content of these measurements from different experimental designs, and the optimal use of such information to yield statistically meaningful answers to biological questions.; Gregory David: The research conducted in our laboratory centers on the interplay between aging and cancer. In particular, we are interested in identifying the cellular hallmarks of aging and their impact on cancer initiation and progression..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in including, have, research, focus using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: David Fenyo + Drew Jones",
    "opportunity_id": "fd281670-a13c-4cd9-a526-7bb67a98d227",
    "opportunity_number": "DE-FOA-0003467",
    "opportunity_title": "SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY",
    "members": [
      "David Fenyo",
      "Drew Jones"
    ],
    "member_ids": [
      "intake_david_fenyo",
      "intake_drew_jones"
    ],
    "rationale": "Shared terms: potential, technologies",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 76.0,
    "opportunity_url": "https://arpa-e-foa.energy.gov",
    "suggested_title": "DE-FOA-0003467 — Biochemistry: apply, problems, tools, developing",
    "synopsis": "This application would address SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY by integrating complementary expertise across the team. The proposed collaboration is centered on apply, problems, tools, developing and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Drew Jones: The ongoing theme of my work is the invention or adaptation of advanced chromatography and mass spectrometry technology to tackle challenging analytical problems with a translational potential. Methodologically, much of my science is designed around using high throughput LC-MS as the analytical readout of biochemical experiments.; David Fenyo: In my research I apply mathematical, statistical and computational methods to provide a detailed understanding of the dynamics of cellular processes through the integration and visualization of data from multiple technologies—including mass spectrometry, next generation sequencing, and microscopy to provide a deeper understanding of biological systems. My focus is the analysis of analytical measurements: the estimation of the information content of these measurements from different experimental designs, and the optimal use of such information to yield statistically meaningful answers to biological questions..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in apply, problems, tools, developing using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Nadav Brandes + Paolo Mita",
    "opportunity_id": "fd281670-a13c-4cd9-a526-7bb67a98d227",
    "opportunity_number": "DE-FOA-0003467",
    "opportunity_title": "SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY",
    "members": [
      "Nadav Brandes",
      "Paolo Mita"
    ],
    "member_ids": [
      "intake_nadav_brandes",
      "intake_paolo_mita"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 73.0,
    "opportunity_url": "https://arpa-e-foa.energy.gov",
    "suggested_title": "DE-FOA-0003467 — Biochemistry: more, only, which, potential",
    "synopsis": "This application would address SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY by integrating complementary expertise across the team. The proposed collaboration is centered on more, only, which, potential and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in more, only, which, potential using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: David Fenyo + Drew Jones",
    "opportunity_id": "ca108e77-69f6-4d3a-9723-a1353076a4ad",
    "opportunity_number": "PAR-26-040",
    "opportunity_title": "Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)",
    "members": [
      "David Fenyo",
      "Drew Jones"
    ],
    "member_ids": [
      "intake_david_fenyo",
      "intake_drew_jones"
    ],
    "rationale": "Shared terms: biology, computational, research, translational",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 35.0,
    "opportunity_url": "https://www.grants.gov/search-results-detail/359003",
    "suggested_title": "PAR-26-040 — Biochemistry: biological, tools, research, improving",
    "synopsis": "This application would address Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) by integrating complementary expertise across the team. The proposed collaboration is centered on biological, tools, research, improving and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Drew Jones: The ongoing theme of my work is the invention or adaptation of advanced chromatography and mass spectrometry technology to tackle challenging analytical problems with a translational potential. Methodologically, much of my science is designed around using high throughput LC-MS as the analytical readout of biochemical experiments.; David Fenyo: In my research I apply mathematical, statistical and computational methods to provide a detailed understanding of the dynamics of cellular processes through the integration and visualization of data from multiple technologies—including mass spectrometry, next generation sequencing, and microscopy to provide a deeper understanding of biological systems. My focus is the analysis of analytical measurements: the estimation of the information content of these measurements from different experimental designs, and the optimal use of such information to yield statistically meaningful answers to biological questions..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in biological, tools, research, improving using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Nadav Brandes + Paolo Mita",
    "opportunity_id": "97a58662-f148-46c2-bacd-1d2147666063",
    "opportunity_number": "RFA-OD-25-011",
    "opportunity_title": "Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)",
    "members": [
      "Nadav Brandes",
      "Paolo Mita"
    ],
    "member_ids": [
      "intake_nadav_brandes",
      "intake_paolo_mita"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 38.0,
    "opportunity_url": "https://www.grants.gov/search-results-detail/359646",
    "suggested_title": "RFA-OD-25-011 — Biochemistry: genetic, models, cells, human",
    "synopsis": "This application would address Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on genetic, models, cells, human and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in genetic, models, cells, human using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: David Fenyo + Gregory David",
    "opportunity_id": "97a58662-f148-46c2-bacd-1d2147666063",
    "opportunity_number": "RFA-OD-25-011",
    "opportunity_title": "Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)",
    "members": [
      "David Fenyo",
      "Gregory David"
    ],
    "member_ids": [
      "intake_david_fenyo",
      "intake_gregory_david"
    ],
    "rationale": "Shared terms: biological, centers",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 31.0,
    "opportunity_url": "https://www.grants.gov/search-results-detail/359646",
    "suggested_title": "RFA-OD-25-011 — Biochemistry: research, have, models, systems",
    "synopsis": "This application would address Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on research, have, models, systems and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: David Fenyo: In my research I apply mathematical, statistical and computational methods to provide a detailed understanding of the dynamics of cellular processes through the integration and visualization of data from multiple technologies—including mass spectrometry, next generation sequencing, and microscopy to provide a deeper understanding of biological systems. My focus is the analysis of analytical measurements: the estimation of the information content of these measurements from different experimental designs, and the optimal use of such information to yield statistically meaningful answers to biological questions.; Gregory David: The research conducted in our laboratory centers on the interplay between aging and cancer. In particular, we are interested in identifying the cellular hallmarks of aging and their impact on cancer initiation and progression..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in research, have, models, systems using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Drew Jones + Michele Pagano",
    "opportunity_id": "5fc9e460-abc2-4c8b-b02e-25090753f213",
    "opportunity_number": "RFA-OD-25-010",
    "opportunity_title": "Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)",
    "members": [
      "Drew Jones",
      "Michele Pagano"
    ],
    "member_ids": [
      "intake_drew_jones",
      "intake_michele_pagano"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 35.0,
    "opportunity_url": "https://www.grants.gov/search-results-detail/359648",
    "suggested_title": "RFA-OD-25-010 — Biochemistry: response, biological, human, approach",
    "synopsis": "This application would address Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on response, biological, human, approach and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Drew Jones: The ongoing theme of my work is the invention or adaptation of advanced chromatography and mass spectrometry technology to tackle challenging analytical problems with a translational potential. Methodologically, much of my science is designed around using high throughput LC-MS as the analytical readout of biochemical experiments.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in response, biological, human, approach using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Gregory David + Nadav Brandes",
    "opportunity_id": "5fc9e460-abc2-4c8b-b02e-25090753f213",
    "opportunity_number": "RFA-OD-25-010",
    "opportunity_title": "Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)",
    "members": [
      "Gregory David",
      "Nadav Brandes"
    ],
    "member_ids": [
      "intake_gregory_david",
      "intake_nadav_brandes"
    ],
    "rationale": "Shared terms: models, research",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 33.0,
    "opportunity_url": "https://www.grants.gov/search-results-detail/359648",
    "suggested_title": "RFA-OD-25-010 — Biochemistry: one, research, have, models",
    "synopsis": "This application would address Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on one, research, have, models and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Gregory David: The research conducted in our laboratory centers on the interplay between aging and cancer. In particular, we are interested in identifying the cellular hallmarks of aging and their impact on cancer initiation and progression..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in one, research, have, models using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Michele Pagano + Nadav Brandes",
    "opportunity_id": "8ad02b0a-1712-4da7-9ce5-247363b661ab",
    "opportunity_number": "W911NF-23-S-0010",
    "opportunity_title": "UNITED STATES ARMY RESEARCH INSTITUTE FOR THE BEHAVIORAL AND SOCIAL SCIENCES (ARI) BROAD AGENCY ANNOUNCEMENT FOR BASIC, APPLIED, AND ADVANCED SCIENTIFIC RESEARCH",
    "members": [
      "Michele Pagano",
      "Nadav Brandes"
    ],
    "member_ids": [
      "intake_michele_pagano",
      "intake_nadav_brandes"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 34.0,
    "opportunity_url": "https://www.grants.gov/search-results-detail/347858",
    "suggested_title": "W911NF-23-S-0010 — Biochemistry: human, can, which, research",
    "synopsis": "This application would address UNITED STATES ARMY RESEARCH INSTITUTE FOR THE BEHAVIORAL AND SOCIAL SCIENCES (ARI) BROAD AGENCY ANNOUNCEMENT FOR BASIC, APPLIED, AND ADVANCED SCIENTIFIC RESEARCH by integrating complementary expertise across the team. The proposed collaboration is centered on human, can, which, research and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in human, can, which, research using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Michele Pagano + Nadav Brandes",
    "opportunity_id": "4cbf781d-7933-4399-a49c-bfb5699b64f0",
    "opportunity_number": "RFA-OH-22-005",
    "opportunity_title": "Commercial Fishing Occupational Safety Research Cooperative Agreement (U01)",
    "members": [
      "Michele Pagano",
      "Nadav Brandes"
    ],
    "member_ids": [
      "intake_michele_pagano",
      "intake_nadav_brandes"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 33.0,
    "opportunity_url": "https://www.grants.gov/search-results-detail/334971",
    "suggested_title": "RFA-OH-22-005 — Biochemistry: research, more, between, new",
    "synopsis": "This application would address Commercial Fishing Occupational Safety Research Cooperative Agreement (U01) by integrating complementary expertise across the team. The proposed collaboration is centered on research, more, between, new and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in research, more, between, new using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Nadav Brandes + Paolo Mita",
    "opportunity_id": "97adaa7a-4d74-44c6-8771-6d061767a40a",
    "opportunity_number": "PAR-25-383",
    "opportunity_title": "Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)",
    "members": [
      "Nadav Brandes",
      "Paolo Mita"
    ],
    "member_ids": [
      "intake_nadav_brandes",
      "intake_paolo_mita"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 31.0,
    "opportunity_url": "http://grants.nih.gov/grants/guide/pa-files/PAR-25-383.html",
    "suggested_title": "PAR-25-383 — Biochemistry: use, clinical, research, more",
    "synopsis": "This application would address Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) by integrating complementary expertise across the team. The proposed collaboration is centered on use, clinical, research, more and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in use, clinical, research, more using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Drew Jones + Gregory David",
    "opportunity_id": "97adaa7a-4d74-44c6-8771-6d061767a40a",
    "opportunity_number": "PAR-25-383",
    "opportunity_title": "Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)",
    "members": [
      "Drew Jones",
      "Gregory David"
    ],
    "member_ids": [
      "intake_drew_jones",
      "intake_gregory_david"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 29.0,
    "opportunity_url": "http://grants.nih.gov/grants/guide/pa-files/PAR-25-383.html",
    "suggested_title": "PAR-25-383 — Biochemistry: its, studies, can, research",
    "synopsis": "This application would address Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) by integrating complementary expertise across the team. The proposed collaboration is centered on its, studies, can, research and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Drew Jones: The ongoing theme of my work is the invention or adaptation of advanced chromatography and mass spectrometry technology to tackle challenging analytical problems with a translational potential. Methodologically, much of my science is designed around using high throughput LC-MS as the analytical readout of biochemical experiments.; Gregory David: The research conducted in our laboratory centers on the interplay between aging and cancer. In particular, we are interested in identifying the cellular hallmarks of aging and their impact on cancer initiation and progression..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in its, studies, can, research using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: David Fenyo + Drew Jones",
    "opportunity_id": "06339d3e-1543-4697-a7ed-345670f2bc0a",
    "opportunity_number": "PAR-25-185",
    "opportunity_title": "Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)",
    "members": [
      "David Fenyo",
      "Drew Jones"
    ],
    "member_ids": [
      "intake_david_fenyo",
      "intake_drew_jones"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 40.0,
    "opportunity_url": "http://grants.nih.gov/grants/guide/pa-files/PAR-25-185.html",
    "suggested_title": "PAR-25-185 — Biochemistry: tools, large, identification, which",
    "synopsis": "This application would address Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on tools, large, identification, which and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: David Fenyo: In my research I apply mathematical, statistical and computational methods to provide a detailed understanding of the dynamics of cellular processes through the integration and visualization of data from multiple technologies—including mass spectrometry, next generation sequencing, and microscopy to provide a deeper understanding of biological systems. My focus is the analysis of analytical measurements: the estimation of the information content of these measurements from different experimental designs, and the optimal use of such information to yield statistically meaningful answers to biological questions.; Drew Jones: The ongoing theme of my work is the invention or adaptation of advanced chromatography and mass spectrometry technology to tackle challenging analytical problems with a translational potential. Methodologically, much of my science is designed around using high throughput LC-MS as the analytical readout of biochemical experiments..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in tools, large, identification, which using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Nadav Brandes + Paolo Mita",
    "opportunity_id": "06339d3e-1543-4697-a7ed-345670f2bc0a",
    "opportunity_number": "PAR-25-185",
    "opportunity_title": "Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)",
    "members": [
      "Nadav Brandes",
      "Paolo Mita"
    ],
    "member_ids": [
      "intake_nadav_brandes",
      "intake_paolo_mita"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 38.0,
    "opportunity_url": "http://grants.nih.gov/grants/guide/pa-files/PAR-25-185.html",
    "suggested_title": "PAR-25-185 — Biochemistry: genetic, models, human, which",
    "synopsis": "This application would address Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on genetic, models, human, which and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in genetic, models, human, which using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Michele Pagano + Nadav Brandes",
    "opportunity_id": "aaa9e158-9d32-4122-ac02-2470defc2f0d",
    "opportunity_number": "PA-25-307",
    "opportunity_title": "NIH Exploratory/Developmental Research Project Grant (Parent R21 Basic Experimental Studies with Humans Required)",
    "members": [
      "Michele Pagano",
      "Nadav Brandes"
    ],
    "member_ids": [
      "intake_michele_pagano",
      "intake_nadav_brandes"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 29.0,
    "opportunity_url": "http://grants.nih.gov/grants/guide/pa-files/PA-25-307.html",
    "suggested_title": "PA-25-307 — Biochemistry: studies, human, research, more",
    "synopsis": "This application would address NIH Exploratory/Developmental Research Project Grant (Parent R21 Basic Experimental Studies with Humans Required) by integrating complementary expertise across the team. The proposed collaboration is centered on studies, human, research, more and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in studies, human, research, more using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Michele Pagano + Nadav Brandes",
    "opportunity_id": "1c7d1763-22ce-42c2-970f-dcc8c6921c6a",
    "opportunity_number": "W911NF-23-S-0003",
    "opportunity_title": "DEVCOM ANALYSIS CENTER BROAD AGENCY ANNOUNCEMENT FOR APPLIED RESEARCH",
    "members": [
      "Michele Pagano",
      "Nadav Brandes"
    ],
    "member_ids": [
      "intake_michele_pagano",
      "intake_nadav_brandes"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 29.0,
    "opportunity_url": "https://www.army.mil/article/261533",
    "suggested_title": "W911NF-23-S-0003 — Biochemistry: research, more, our, concepts",
    "synopsis": "This application would address DEVCOM ANALYSIS CENTER BROAD AGENCY ANNOUNCEMENT FOR APPLIED RESEARCH by integrating complementary expertise across the team. The proposed collaboration is centered on research, more, our, concepts and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in research, more, our, concepts using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Nadav Brandes + Paolo Mita",
    "opportunity_id": "f0b6f88d-7241-42c5-ae81-ffff4c01f04e",
    "opportunity_number": "RFA-HL-26-020",
    "opportunity_title": "Catalyze: Product Definition  Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)",
    "members": [
      "Nadav Brandes",
      "Paolo Mita"
    ],
    "member_ids": [
      "intake_nadav_brandes",
      "intake_paolo_mita"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 31.0,
    "opportunity_url": "http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-26-020.html",
    "suggested_title": "RFA-HL-26-020 — Biochemistry: use, human, clinical, research",
    "synopsis": "This application would address Catalyze: Product Definition  Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on use, human, clinical, research and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome.; Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in use, human, clinical, research using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: David Fenyo + Drew Jones",
    "opportunity_id": "b2b577a9-12ef-4005-b962-2d3922b922bf",
    "opportunity_number": "RFA-HL-26-019",
    "opportunity_title": "Catalyze Product Definition  Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)",
    "members": [
      "David Fenyo",
      "Drew Jones"
    ],
    "member_ids": [
      "intake_david_fenyo",
      "intake_drew_jones"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 39.0,
    "opportunity_url": "http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-26-019.html",
    "suggested_title": "RFA-HL-26-019 — Biochemistry: tools, large, translational, identification",
    "synopsis": "This application would address Catalyze Product Definition  Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on tools, large, translational, identification and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: David Fenyo: In my research I apply mathematical, statistical and computational methods to provide a detailed understanding of the dynamics of cellular processes through the integration and visualization of data from multiple technologies—including mass spectrometry, next generation sequencing, and microscopy to provide a deeper understanding of biological systems. My focus is the analysis of analytical measurements: the estimation of the information content of these measurements from different experimental designs, and the optimal use of such information to yield statistically meaningful answers to biological questions.; Drew Jones: The ongoing theme of my work is the invention or adaptation of advanced chromatography and mass spectrometry technology to tackle challenging analytical problems with a translational potential. Methodologically, much of my science is designed around using high throughput LC-MS as the analytical readout of biochemical experiments..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in tools, large, translational, identification using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "pair",
    "team_name": "Biochemistry and Molecular Pharmacology pair: Nadav Brandes + Paolo Mita",
    "opportunity_id": "b2b577a9-12ef-4005-b962-2d3922b922bf",
    "opportunity_number": "RFA-HL-26-019",
    "opportunity_title": "Catalyze Product Definition  Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)",
    "members": [
      "Nadav Brandes",
      "Paolo Mita"
    ],
    "member_ids": [
      "intake_nadav_brandes",
      "intake_paolo_mita"
    ],
    "rationale": "Low lexical overlap; plausible conceptual fit based on general scope.",
    "suggested_specific_aim": "Define a focused pilot that ties the opportunity deliverable to an existing departmental strength and a measurable endpoint.",
    "next_steps": "Confirm eligibility and scope, assign a lead, draft a one page concept, and map resources and preliminary data needs.",
    "confidence": "medium",
    "confidence_score": 34.0,
    "opportunity_url": "http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-26-019.html",
    "suggested_title": "RFA-HL-26-019 — Biochemistry: human, clinical, research, potential",
    "synopsis": "This application would address Catalyze Product Definition  Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on human, clinical, research, potential and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in human, clinical, research, potential using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "team",
    "team_name": "Biochemistry and Molecular Pharmacology team: Michele Pagano, Nadav Brandes et al",
    "opportunity_id": "ac5709b0-e4ba-4653-a2b9-2087cb1c9b42",
    "opportunity_number": "SFOP0009339",
    "opportunity_title": "Notice of Intent:  Program to End Modern Slavery FY 2023",
    "members": [
      "Michele Pagano",
      "Nadav Brandes",
      "Paolo Mita",
      "Pau Castel"
    ],
    "member_ids": [
      "intake_michele_pagano",
      "intake_nadav_brandes",
      "intake_paolo_mita",
      "intake_pau_castel"
    ],
    "rationale": "Team spans complementary expertise aligned to the opportunity scope based on summary keyword overlap.",
    "suggested_specific_aim": "Propose an integrated workflow where each member owns a module contributing to one coherent milestone driven plan.",
    "next_steps": "Hold a 30 minute scoping call, align roles to milestones, identify data gaps, and draft an outline plus budget sketch.",
    "confidence": "medium",
    "confidence_score": 52.0,
    "opportunity_url": "https://mygrants.servicenowservices.com/overseas?id=&table=x_g_usd4_d_grant_funding_opportunity&sys_id=38cfa11887544ed01b4742270cbb350d&view=Default",
    "suggested_title": "SFOP0009339 — Biochemistry: which, research, human, has",
    "synopsis": "This application would address Notice of Intent:  Program to End Modern Slavery FY 2023 by integrating complementary expertise across the team. The proposed collaboration is centered on which, research, human, has and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer.; Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome.; Pau Castel: The Castel laboratory is interested in understanding the molecular mechanisms underlying oncoprotein-mediated transformation. Our laboratory uses biochemical, cell signaling, mouse modeling, and pharmacological approaches to elucidate the functions and regulation of different oncoproteins in cancer and congenital disorders..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in which, research, human, has using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "team",
    "team_name": "Biochemistry and Molecular Pharmacology team: David Fenyo, Drew Jones et al",
    "opportunity_id": "e66f1f91-42dc-4a57-acba-8986d3e08df1",
    "opportunity_number": "DE-FOA-0002265",
    "opportunity_title": "University Nuclear Leadership Program– Scholarship and Fellowship Support",
    "members": [
      "David Fenyo",
      "Drew Jones",
      "Gregory David",
      "Michele Pagano"
    ],
    "member_ids": [
      "intake_david_fenyo",
      "intake_drew_jones",
      "intake_gregory_david",
      "intake_michele_pagano"
    ],
    "rationale": "Team spans complementary expertise aligned to the opportunity scope based on summary keyword overlap.",
    "suggested_specific_aim": "Propose an integrated workflow where each member owns a module contributing to one coherent milestone driven plan.",
    "next_steps": "Hold a 30 minute scoping call, align roles to milestones, identify data gaps, and draft an outline plus budget sketch.",
    "confidence": "medium",
    "confidence_score": 57.0,
    "opportunity_url": "https://neup.inl.gov/SitePages/Home.aspx",
    "suggested_title": "DE-FOA-0002265 — Biochemistry: research, which, our, can",
    "synopsis": "This application would address University Nuclear Leadership Program– Scholarship and Fellowship Support by integrating complementary expertise across the team. The proposed collaboration is centered on research, which, our, can and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Drew Jones: The ongoing theme of my work is the invention or adaptation of advanced chromatography and mass spectrometry technology to tackle challenging analytical problems with a translational potential. Methodologically, much of my science is designed around using high throughput LC-MS as the analytical readout of biochemical experiments.; David Fenyo: In my research I apply mathematical, statistical and computational methods to provide a detailed understanding of the dynamics of cellular processes through the integration and visualization of data from multiple technologies—including mass spectrometry, next generation sequencing, and microscopy to provide a deeper understanding of biological systems. My focus is the analysis of analytical measurements: the estimation of the information content of these measurements from different experimental designs, and the optimal use of such information to yield statistically meaningful answers to biological questions.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer.; Gregory David: The research conducted in our laboratory centers on the interplay between aging and cancer. In particular, we are interested in identifying the cellular hallmarks of aging and their impact on cancer initiation and progression..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in research, which, our, can using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "team",
    "team_name": "Biochemistry and Molecular Pharmacology team: Michele Pagano, Nadav Brandes et al",
    "opportunity_id": "e66f1f91-42dc-4a57-acba-8986d3e08df1",
    "opportunity_number": "DE-FOA-0002265",
    "opportunity_title": "University Nuclear Leadership Program– Scholarship and Fellowship Support",
    "members": [
      "Michele Pagano",
      "Nadav Brandes",
      "Paolo Mita",
      "Pau Castel"
    ],
    "member_ids": [
      "intake_michele_pagano",
      "intake_nadav_brandes",
      "intake_paolo_mita",
      "intake_pau_castel"
    ],
    "rationale": "Team spans complementary expertise aligned to the opportunity scope based on summary keyword overlap.",
    "suggested_specific_aim": "Propose an integrated workflow where each member owns a module contributing to one coherent milestone driven plan.",
    "next_steps": "Hold a 30 minute scoping call, align roles to milestones, identify data gaps, and draft an outline plus budget sketch.",
    "confidence": "medium",
    "confidence_score": 52.0,
    "opportunity_url": "https://neup.inl.gov/SitePages/Home.aspx",
    "suggested_title": "DE-FOA-0002265 — Biochemistry: which, research, our, new",
    "synopsis": "This application would address University Nuclear Leadership Program– Scholarship and Fellowship Support by integrating complementary expertise across the team. The proposed collaboration is centered on which, research, our, new and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer.; Pau Castel: The Castel laboratory is interested in understanding the molecular mechanisms underlying oncoprotein-mediated transformation. Our laboratory uses biochemical, cell signaling, mouse modeling, and pharmacological approaches to elucidate the functions and regulation of different oncoproteins in cancer and congenital disorders..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in which, research, our, new using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "team",
    "team_name": "Biochemistry and Molecular Pharmacology team: David Fenyo, Gregory David et al",
    "opportunity_id": "cd4dd647-b2b4-49d9-aac3-0033d0eb434c",
    "opportunity_number": "DE-FOA-0003164",
    "opportunity_title": "SPURRING PROJECTS TO ADVANCE ENERGY RESEARCH AND KNOWLEDGE SWIFTLY (SPARKS)",
    "members": [
      "David Fenyo",
      "Gregory David",
      "Paolo Mita"
    ],
    "member_ids": [
      "intake_david_fenyo",
      "intake_gregory_david",
      "intake_paolo_mita"
    ],
    "rationale": "Team spans complementary expertise aligned to the opportunity scope based on summary keyword overlap.",
    "suggested_specific_aim": "Propose an integrated workflow where each member owns a module contributing to one coherent milestone driven plan.",
    "next_steps": "Hold a 30 minute scoping call, align roles to milestones, identify data gaps, and draft an outline plus budget sketch.",
    "confidence": "medium",
    "confidence_score": 69.0,
    "opportunity_url": "https://arpa-e-foa.energy.gov",
    "suggested_title": "DE-FOA-0003164 — Biochemistry: including, research, tools, which",
    "synopsis": "This application would address SPURRING PROJECTS TO ADVANCE ENERGY RESEARCH AND KNOWLEDGE SWIFTLY (SPARKS) by integrating complementary expertise across the team. The proposed collaboration is centered on including, research, tools, which and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: David Fenyo: In my research I apply mathematical, statistical and computational methods to provide a detailed understanding of the dynamics of cellular processes through the integration and visualization of data from multiple technologies—including mass spectrometry, next generation sequencing, and microscopy to provide a deeper understanding of biological systems. My focus is the analysis of analytical measurements: the estimation of the information content of these measurements from different experimental designs, and the optimal use of such information to yield statistically meaningful answers to biological questions.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome.; Gregory David: The research conducted in our laboratory centers on the interplay between aging and cancer. In particular, we are interested in identifying the cellular hallmarks of aging and their impact on cancer initiation and progression..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in including, research, tools, which using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "team",
    "team_name": "Biochemistry and Molecular Pharmacology team: Michele Pagano, Nadav Brandes et al",
    "opportunity_id": "fd281670-a13c-4cd9-a526-7bb67a98d227",
    "opportunity_number": "DE-FOA-0003467",
    "opportunity_title": "SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY",
    "members": [
      "Michele Pagano",
      "Nadav Brandes",
      "Paolo Mita",
      "Pau Castel"
    ],
    "member_ids": [
      "intake_michele_pagano",
      "intake_nadav_brandes",
      "intake_paolo_mita",
      "intake_pau_castel"
    ],
    "rationale": "Team spans complementary expertise aligned to the opportunity scope based on summary keyword overlap.",
    "suggested_specific_aim": "Propose an integrated workflow where each member owns a module contributing to one coherent milestone driven plan.",
    "next_steps": "Hold a 30 minute scoping call, align roles to milestones, identify data gaps, and draft an outline plus budget sketch.",
    "confidence": "medium",
    "confidence_score": 118.0,
    "opportunity_url": "https://arpa-e-foa.energy.gov",
    "suggested_title": "DE-FOA-0003467 — Biochemistry: more, which, research, their",
    "synopsis": "This application would address SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY by integrating complementary expertise across the team. The proposed collaboration is centered on more, which, research, their and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome.; Pau Castel: The Castel laboratory is interested in understanding the molecular mechanisms underlying oncoprotein-mediated transformation. Our laboratory uses biochemical, cell signaling, mouse modeling, and pharmacological approaches to elucidate the functions and regulation of different oncoproteins in cancer and congenital disorders..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in more, which, research, their using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "team",
    "team_name": "Biochemistry and Molecular Pharmacology team: David Fenyo, Drew Jones et al",
    "opportunity_id": "fd281670-a13c-4cd9-a526-7bb67a98d227",
    "opportunity_number": "DE-FOA-0003467",
    "opportunity_title": "SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY",
    "members": [
      "David Fenyo",
      "Drew Jones",
      "Alexander Serganov"
    ],
    "member_ids": [
      "intake_david_fenyo",
      "intake_drew_jones",
      "intake_alexander_serganov"
    ],
    "rationale": "Team spans complementary expertise aligned to the opportunity scope based on summary keyword overlap.",
    "suggested_specific_aim": "Propose an integrated workflow where each member owns a module contributing to one coherent milestone driven plan.",
    "next_steps": "Hold a 30 minute scoping call, align roles to milestones, identify data gaps, and draft an outline plus budget sketch.",
    "confidence": "medium",
    "confidence_score": 80.0,
    "opportunity_url": "https://arpa-e-foa.energy.gov",
    "suggested_title": "DE-FOA-0003467 — Biochemistry: apply, problems, tools, developing",
    "synopsis": "This application would address SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY by integrating complementary expertise across the team. The proposed collaboration is centered on apply, problems, tools, developing and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Drew Jones: The ongoing theme of my work is the invention or adaptation of advanced chromatography and mass spectrometry technology to tackle challenging analytical problems with a translational potential. Methodologically, much of my science is designed around using high throughput LC-MS as the analytical readout of biochemical experiments.; David Fenyo: In my research I apply mathematical, statistical and computational methods to provide a detailed understanding of the dynamics of cellular processes through the integration and visualization of data from multiple technologies—including mass spectrometry, next generation sequencing, and microscopy to provide a deeper understanding of biological systems. My focus is the analysis of analytical measurements: the estimation of the information content of these measurements from different experimental designs, and the optimal use of such information to yield statistically meaningful answers to biological questions.; Alexander Serganov: We use a combination of biophysical methods, biochemical techniques, and structural approaches, including X-ray crystallography and cryo-electron microscopy, to elucidate molecular mechanisms of fundamental cellular processes associated with biosynthesis of RNA, metabolism of RNA, and RNA-mediated gene expression control. We study Fragile X syndrome and antibiotic resistance..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in apply, problems, tools, developing using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "team",
    "team_name": "Biochemistry and Molecular Pharmacology team: Michele Pagano, Nadav Brandes et al",
    "opportunity_id": "97a58662-f148-46c2-bacd-1d2147666063",
    "opportunity_number": "RFA-OD-25-011",
    "opportunity_title": "Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)",
    "members": [
      "Michele Pagano",
      "Nadav Brandes",
      "Paolo Mita",
      "Pau Castel"
    ],
    "member_ids": [
      "intake_michele_pagano",
      "intake_nadav_brandes",
      "intake_paolo_mita",
      "intake_pau_castel"
    ],
    "rationale": "Team spans complementary expertise aligned to the opportunity scope based on summary keyword overlap.",
    "suggested_specific_aim": "Propose an integrated workflow where each member owns a module contributing to one coherent milestone driven plan.",
    "next_steps": "Hold a 30 minute scoping call, align roles to milestones, identify data gaps, and draft an outline plus budget sketch.",
    "confidence": "medium",
    "confidence_score": 62.0,
    "opportunity_url": "https://www.grants.gov/search-results-detail/359646",
    "suggested_title": "RFA-OD-25-011 — Biochemistry: cell, models, research, human",
    "synopsis": "This application would address Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on cell, models, research, human and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer.; Pau Castel: The Castel laboratory is interested in understanding the molecular mechanisms underlying oncoprotein-mediated transformation. Our laboratory uses biochemical, cell signaling, mouse modeling, and pharmacological approaches to elucidate the functions and regulation of different oncoproteins in cancer and congenital disorders..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in cell, models, research, human using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "team",
    "team_name": "Biochemistry and Molecular Pharmacology team: Gregory David, Nadav Brandes et al",
    "opportunity_id": "5fc9e460-abc2-4c8b-b02e-25090753f213",
    "opportunity_number": "RFA-OD-25-010",
    "opportunity_title": "Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)",
    "members": [
      "Gregory David",
      "Nadav Brandes",
      "Paolo Mita",
      "Alexander Serganov"
    ],
    "member_ids": [
      "intake_gregory_david",
      "intake_nadav_brandes",
      "intake_paolo_mita",
      "intake_alexander_serganov"
    ],
    "rationale": "Team spans complementary expertise aligned to the opportunity scope based on summary keyword overlap.",
    "suggested_specific_aim": "Propose an integrated workflow where each member owns a module contributing to one coherent milestone driven plan.",
    "next_steps": "Hold a 30 minute scoping call, align roles to milestones, identify data gaps, and draft an outline plus budget sketch.",
    "confidence": "medium",
    "confidence_score": 54.0,
    "opportunity_url": "https://www.grants.gov/search-results-detail/359648",
    "suggested_title": "RFA-OD-25-010 — Biochemistry: research, models, also, including",
    "synopsis": "This application would address Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on research, models, also, including and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome.; Gregory David: The research conducted in our laboratory centers on the interplay between aging and cancer. In particular, we are interested in identifying the cellular hallmarks of aging and their impact on cancer initiation and progression.; Alexander Serganov: We use a combination of biophysical methods, biochemical techniques, and structural approaches, including X-ray crystallography and cryo-electron microscopy, to elucidate molecular mechanisms of fundamental cellular processes associated with biosynthesis of RNA, metabolism of RNA, and RNA-mediated gene expression control. We study Fragile X syndrome and antibiotic resistance..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in research, models, also, including using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "team",
    "team_name": "Biochemistry and Molecular Pharmacology team: Michele Pagano, Nadav Brandes et al",
    "opportunity_id": "97adaa7a-4d74-44c6-8771-6d061767a40a",
    "opportunity_number": "PAR-25-383",
    "opportunity_title": "Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)",
    "members": [
      "Michele Pagano",
      "Nadav Brandes",
      "Paolo Mita",
      "Pau Castel"
    ],
    "member_ids": [
      "intake_michele_pagano",
      "intake_nadav_brandes",
      "intake_paolo_mita",
      "intake_pau_castel"
    ],
    "rationale": "Team spans complementary expertise aligned to the opportunity scope based on summary keyword overlap.",
    "suggested_specific_aim": "Propose an integrated workflow where each member owns a module contributing to one coherent milestone driven plan.",
    "next_steps": "Hold a 30 minute scoping call, align roles to milestones, identify data gaps, and draft an outline plus budget sketch.",
    "confidence": "medium",
    "confidence_score": 60.0,
    "opportunity_url": "http://grants.nih.gov/grants/guide/pa-files/PAR-25-383.html",
    "suggested_title": "PAR-25-383 — Biochemistry: research, more, use, therapeutic",
    "synopsis": "This application would address Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) by integrating complementary expertise across the team. The proposed collaboration is centered on research, more, use, therapeutic and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome.; Pau Castel: The Castel laboratory is interested in understanding the molecular mechanisms underlying oncoprotein-mediated transformation. Our laboratory uses biochemical, cell signaling, mouse modeling, and pharmacological approaches to elucidate the functions and regulation of different oncoproteins in cancer and congenital disorders..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in research, more, use, therapeutic using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "team",
    "team_name": "Biochemistry and Molecular Pharmacology team: David Fenyo, Drew Jones et al",
    "opportunity_id": "06339d3e-1543-4697-a7ed-345670f2bc0a",
    "opportunity_number": "PAR-25-185",
    "opportunity_title": "Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)",
    "members": [
      "David Fenyo",
      "Drew Jones",
      "Gregory David",
      "Michele Pagano"
    ],
    "member_ids": [
      "intake_david_fenyo",
      "intake_drew_jones",
      "intake_gregory_david",
      "intake_michele_pagano"
    ],
    "rationale": "Team spans complementary expertise aligned to the opportunity scope based on summary keyword overlap.",
    "suggested_specific_aim": "Propose an integrated workflow where each member owns a module contributing to one coherent milestone driven plan.",
    "next_steps": "Hold a 30 minute scoping call, align roles to milestones, identify data gaps, and draft an outline plus budget sketch.",
    "confidence": "medium",
    "confidence_score": 63.0,
    "opportunity_url": "http://grants.nih.gov/grants/guide/pa-files/PAR-25-185.html",
    "suggested_title": "PAR-25-185 — Biochemistry: have, research, models, including",
    "synopsis": "This application would address Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on have, research, models, including and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: David Fenyo: In my research I apply mathematical, statistical and computational methods to provide a detailed understanding of the dynamics of cellular processes through the integration and visualization of data from multiple technologies—including mass spectrometry, next generation sequencing, and microscopy to provide a deeper understanding of biological systems. My focus is the analysis of analytical measurements: the estimation of the information content of these measurements from different experimental designs, and the optimal use of such information to yield statistically meaningful answers to biological questions.; Drew Jones: The ongoing theme of my work is the invention or adaptation of advanced chromatography and mass spectrometry technology to tackle challenging analytical problems with a translational potential. Methodologically, much of my science is designed around using high throughput LC-MS as the analytical readout of biochemical experiments.; Gregory David: The research conducted in our laboratory centers on the interplay between aging and cancer. In particular, we are interested in identifying the cellular hallmarks of aging and their impact on cancer initiation and progression.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in have, research, models, including using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "team",
    "team_name": "Biochemistry and Molecular Pharmacology team: Michele Pagano, Nadav Brandes et al",
    "opportunity_id": "06339d3e-1543-4697-a7ed-345670f2bc0a",
    "opportunity_number": "PAR-25-185",
    "opportunity_title": "Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)",
    "members": [
      "Michele Pagano",
      "Nadav Brandes",
      "Paolo Mita",
      "Pau Castel"
    ],
    "member_ids": [
      "intake_michele_pagano",
      "intake_nadav_brandes",
      "intake_paolo_mita",
      "intake_pau_castel"
    ],
    "rationale": "Team spans complementary expertise aligned to the opportunity scope based on summary keyword overlap.",
    "suggested_specific_aim": "Propose an integrated workflow where each member owns a module contributing to one coherent milestone driven plan.",
    "next_steps": "Hold a 30 minute scoping call, align roles to milestones, identify data gaps, and draft an outline plus budget sketch.",
    "confidence": "medium",
    "confidence_score": 53.0,
    "opportunity_url": "http://grants.nih.gov/grants/guide/pa-files/PAR-25-185.html",
    "suggested_title": "PAR-25-185 — Biochemistry: which, research, models, human",
    "synopsis": "This application would address Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on which, research, models, human and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer.; Pau Castel: The Castel laboratory is interested in understanding the molecular mechanisms underlying oncoprotein-mediated transformation. Our laboratory uses biochemical, cell signaling, mouse modeling, and pharmacological approaches to elucidate the functions and regulation of different oncoproteins in cancer and congenital disorders..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in which, research, models, human using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "team",
    "team_name": "Biochemistry and Molecular Pharmacology team: David Fenyo, Drew Jones et al",
    "opportunity_id": "b2b577a9-12ef-4005-b962-2d3922b922bf",
    "opportunity_number": "RFA-HL-26-019",
    "opportunity_title": "Catalyze Product Definition  Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)",
    "members": [
      "David Fenyo",
      "Drew Jones",
      "Gregory David",
      "Michele Pagano"
    ],
    "member_ids": [
      "intake_david_fenyo",
      "intake_drew_jones",
      "intake_gregory_david",
      "intake_michele_pagano"
    ],
    "rationale": "Team spans complementary expertise aligned to the opportunity scope based on summary keyword overlap.",
    "suggested_specific_aim": "Propose an integrated workflow where each member owns a module contributing to one coherent milestone driven plan.",
    "next_steps": "Hold a 30 minute scoping call, align roles to milestones, identify data gaps, and draft an outline plus budget sketch.",
    "confidence": "medium",
    "confidence_score": 60.0,
    "opportunity_url": "http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-26-019.html",
    "suggested_title": "RFA-HL-26-019 — Biochemistry: have, research, therapeutic, can",
    "synopsis": "This application would address Catalyze Product Definition  Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on have, research, therapeutic, can and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: David Fenyo: In my research I apply mathematical, statistical and computational methods to provide a detailed understanding of the dynamics of cellular processes through the integration and visualization of data from multiple technologies—including mass spectrometry, next generation sequencing, and microscopy to provide a deeper understanding of biological systems. My focus is the analysis of analytical measurements: the estimation of the information content of these measurements from different experimental designs, and the optimal use of such information to yield statistically meaningful answers to biological questions.; Drew Jones: The ongoing theme of my work is the invention or adaptation of advanced chromatography and mass spectrometry technology to tackle challenging analytical problems with a translational potential. Methodologically, much of my science is designed around using high throughput LC-MS as the analytical readout of biochemical experiments.; Gregory David: The research conducted in our laboratory centers on the interplay between aging and cancer. In particular, we are interested in identifying the cellular hallmarks of aging and their impact on cancer initiation and progression.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in have, research, therapeutic, can using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  },
  {
    "team_type": "team",
    "team_name": "Biochemistry and Molecular Pharmacology team: Michele Pagano, Nadav Brandes et al",
    "opportunity_id": "b2b577a9-12ef-4005-b962-2d3922b922bf",
    "opportunity_number": "RFA-HL-26-019",
    "opportunity_title": "Catalyze Product Definition  Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)",
    "members": [
      "Michele Pagano",
      "Nadav Brandes",
      "Paolo Mita",
      "Pau Castel"
    ],
    "member_ids": [
      "intake_michele_pagano",
      "intake_nadav_brandes",
      "intake_paolo_mita",
      "intake_pau_castel"
    ],
    "rationale": "Team spans complementary expertise aligned to the opportunity scope based on summary keyword overlap.",
    "suggested_specific_aim": "Propose an integrated workflow where each member owns a module contributing to one coherent milestone driven plan.",
    "next_steps": "Hold a 30 minute scoping call, align roles to milestones, identify data gaps, and draft an outline plus budget sketch.",
    "confidence": "medium",
    "confidence_score": 56.0,
    "opportunity_url": "http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-26-019.html",
    "suggested_title": "RFA-HL-26-019 — Biochemistry: research, human, therapeutic, diseases",
    "synopsis": "This application would address Catalyze Product Definition  Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) by integrating complementary expertise across the team. The proposed collaboration is centered on research, human, therapeutic, diseases and is designed to produce a cohesive, milestone-driven set of deliverables.",
    "rationale_detailed": "Faculty were selected for strong topical overlap with the opportunity and complementary, non-redundant strengths. Key contributions: Nadav Brandes: Large Language Models (LLMs) have revolutionized Artificial intelligence (AI). Despite being originally designed for text, these models turn out to be incredibly effective for biological sequences like DNA and proteins.; Paolo Mita: Transposable elements (TE) are sequences of DNA that are capable of moving within a host genome, and thus are often referred to as “jumping genes.” DNA transposons use a “cut and paste” mechanism to move within a host genome while retrotransposons increase their amount using a “copy and paste” process. My research focuses on the study of the Long Interspersed Element-1 (LINE-1 or L1) retrotransposon, which is the only TE capable of autonomously \"jumping\" within the human genome.; Pau Castel: The Castel laboratory is interested in understanding the molecular mechanisms underlying oncoprotein-mediated transformation. Our laboratory uses biochemical, cell signaling, mouse modeling, and pharmacological approaches to elucidate the functions and regulation of different oncoproteins in cancer and congenital disorders.; Michele Pagano: Our laboratory is interested in how ubiquitin-mediated proteolysis controls the three key dimensions of cellular life:  proliferation, survival, and differentiation. Specifically, we aim at dissecting the biochemical and molecular mechanisms behind fundamental cellular processes that, when deregulated, result in cancer..",
    "suggested_aims": [
      "Aim 1: Define and quantify the core problem space in research, human, therapeutic, diseases using the team’s established models and datasets.",
      "Aim 2: Develop and optimize an integrated approach that leverages each investigator’s strengths to address the opportunity requirements.",
      "Aim 3: Validate outcomes in the most relevant system and deliver a clear translational or mechanistic endpoint aligned to the FOA."
    ]
  }
]
